Dana Alexander
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Dana Alexander
Galera Therapeutics, Inc. reported in an 8-K filed August 4, 2026 that Dana Alexander was appointed officers of the Company, effective August 3, 2026.
“Effective upon the closing of the Mergers, on August 3, 2026, Madan Jagasia, Julie Feder, Parameswaran Hari, and Dana Alexander were appointed as officers of the Company (as the surviving corporation in the Galera Merger).”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Current
2026-08-03–present
Company network
Recorded roles and call appearances connecting this person to public companies.
Leadership on record at Galera Therapeutics, Inc.
Other people whose current roles at this company are on record from its filings.
- Joel Sussman Chief Accounting Officer
- Michael Friedman Board Member
- Nancy Chang, Ph.D. Board Member
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.